Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017203
Filing Date
2019-05-08
Accepted
2019-05-08 16:13:24
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q advm-10q_20190331.htm 10-Q 1507206
2 EX-10.1 advm-ex101_157.htm EX-10.1 29394
3 EX-31.1 advm-ex311_33.htm EX-31.1 19296
4 EX-31.2 advm-ex312_31.htm EX-31.2 18720
5 EX-32.1 advm-ex321_32.htm EX-32.1 11224
6 EX-32.2 advm-ex322_139.htm EX-32.2 11218
7 GRAPHIC gu3r1gee0dk4000001.jpg GRAPHIC 21907
  Complete submission text file 0001564590-19-017203.txt   4221258

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT advm-20190331.xml EX-101.INS 702385
9 XBRL TAXONOMY EXTENSION SCHEMA advm-20190331.xsd EX-101.SCH 30463
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE advm-20190331_cal.xml EX-101.CAL 43532
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE advm-20190331_def.xml EX-101.DEF 78235
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20190331_lab.xml EX-101.LAB 260081
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20190331_pre.xml EX-101.PRE 181313
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 19806748
SIC: 2836 Biological Products, (No Diagnostic Substances)